New therapeutic target for most common solid cancer in childhood?
Tuesday, February 16, 2010 - 06:14
in Health & Medicine
A team of researchers, led by Patrick Mehlen, at Universite de Lyon, France, has identified the protein NT-3 and the cell-surface molecule to which it binds (TrkC) as potential therapeutic targets for the treatment of neuroblastoma - the most frequent solid tumour in young children - by studying human neuroblastoma cells in vitro and after xenotransplantation into mice and chicks...